Keyphrases
Carrier State
100%
Daycare Centers
100%
Haemophilus Influenzae
100%
Rifampin
100%
Influenza B
100%
Fresno
25%
Clinical Trials
12%
Cellulitis
12%
Healthy children
12%
Young children
12%
Meningitis
12%
Clinical Setting
12%
Controlled Experiment
12%
Trimethoprim-sulfamethoxazole (TMP-SMX)
12%
Control Population
12%
Clinical Support
12%
Serious Illness
12%
Colonization Rate
12%
Closed Population
12%
Family Contact
12%
Nasopharyngeal Microbiota
12%
Medicine and Dentistry
Disease
100%
Haemophilus Influenzae Type B
100%
Haemophilus influenzae
100%
Rifampicin
100%
Heterozygote
100%
Clinical Trial
16%
Infection
16%
In Vitro
16%
Meningitis
16%
Cellulitis
16%
Population Dynamics
16%
Toddlers
16%
Controlled Clinical Trial
16%
Trimethoprim/Sulfamethoxazole
16%
Population
16%
Isoniazid
16%
Pharmacology, Toxicology and Pharmaceutical Science
Haemophilus Influenzae Type B
100%
Haemophilus influenzae
100%
Rifampicin
100%
Disease
100%
Clinical Trial
16%
Controlled Clinical Trial
16%
Infection
16%
Cotrimoxazole
16%
Cellulitis
16%
Meningitis
16%
Isoniazid
16%